Semaglutide (Ozempic, Wegovy) and the eyes: sudden vision loss, diabetic eye checks and what to tell your doctor
Someone in the family uses semaglutide for diabetes or weight and has read a headline about the eyes. Here is what has been reported, what is still uncertain, why the diabetic eye check still matters, and what to tell the prescriber and the eye doctor.
Go to an emergency department or eye casualty the same day if, on semaglutide, someone…I see parents and grandparents for squint, cataract and everyday eye problems, I operate on squint and cataract, and I perform LASIK, SMILE and Presbyond for adults, so one family can keep one eye doctor. Family eye care Where I practise
- Europe's medicines regulator calls NAION, a sudden optic nerve problem, a very rare side effect of semaglutide, up to 1 in 10,000 people, and eye doctors say a causal link is not yet established.
- Sudden, painless loss of vision in one eye, or a dark patch that does not clear, needs an emergency department or eye casualty unit the same day.
- Diabetic retinopathy can worsen early in some people who already have it, so the dilated diabetic eye check should not be skipped after starting.
- Blurred vision in the first months is often the lens adjusting to changing blood sugar and usually settles, but tell the eye doctor before ordering new glasses.
- Never stop semaglutide on your own. Tell the prescribing doctor and the eye doctor, and let the two of them decide.
Someone in the family is using semaglutide, sold as Ozempic, Wegovy and Rybelsus, for diabetes or for weight, and has read a headline about the eyes. This page sets out what has been reported, what is still uncertain, why the diabetic eye check still matters, and what to tell the doctors. Semaglutide belongs to the GLP-1 medicines, which act on the hormone that tells the body it has eaten.
One rule comes first. Do not stop or change semaglutide on your own because of anything on this page. Speak to the doctor who prescribes it. The American Academy of Ophthalmology says the same: it asks patients not to stop a GLP-1 medicine alone, and to see an ophthalmologist promptly if sudden, painless vision loss in one eye appears.
Can semaglutide cause sudden vision loss?
Very rarely, it may. In June 2025 the European Medicines Agency's safety committee concluded that non-arteritic anterior ischaemic optic neuropathy, shortened to NAION, is a very rare side effect of semaglutide, meaning it may affect up to 1 in 10,000 people taking it. It said several large studies in adults with type 2 diabetes suggest about a two-fold rise in risk, which works out at about one extra case for every 10,000 years of treatment.
The American Academy of Ophthalmology is more cautious about cause. It describes NAION as rare, says any added risk appears small, and says it has not been established that these medicines cause it. Its neuro-ophthalmologist adds that it is premature to call the link causal, and that people with diabetes are already at risk of NAION whether or not they use semaglutide. The same page reports that the US FDA has asked manufacturers of GLP-1 medicines to add a warning.
So the honest summary is a signal, not a verdict. The risk for any one person is small, the doctors who study it disagree on how much is the medicine and how much is the diabetes, and the sensible response is to know the warning sign. The Retreat Clinic's page on weight-loss injections and your eyes looks at the same question from the prescribing side.
What does NAION look like, and what do we do the same day?
It looks like sudden loss of vision in one eye, usually without pain, and the answer is to be seen the same day. NAION means the blood supply to the front of the optic nerve, the cable that carries sight to the brain, has dropped. The AAO describes it as sudden, painless vision loss in one eye. The NHS lists sudden loss of vision, usually in one eye at a time, among the serious side effects of semaglutide.
The AAO's page on ischaemic optic neuropathy also names the people more likely to get it, with or without any medicine: high blood pressure, high cholesterol, sleep apnoea, heart disease, diabetes and age 50 or over. It notes that vision may darken for a few seconds or minutes and then return, and that this can come before the nerve is affected, so a brief episode is also a reason to call at once.
The same page says there is no treatment that restores vision lost to this condition, which is why speed and a proper diagnosis matter more than waiting to see if it clears. Go to an emergency department or an eye casualty unit and tell them which medicine is being used.
The European Medicines Agency says treatment should be stopped if NAION is confirmed. That is a decision for the doctors who confirm it, not something to do on the way to hospital. Our page on sudden loss of vision in one eye explains why this counts as an emergency.
Can semaglutide make diabetic retinopathy worse?
In some people with diabetes who already have retinopathy, yes, early on, and the product label says so. Diabetic retinopathy is damage to the small blood vessels at the back of the eye caused by diabetes. The US label for the semaglutide injection describes a two-year trial in people with type 2 diabetes and high heart risk. More diabetic retinopathy complications occurred on semaglutide (3.0 per cent) than on placebo (1.8 per cent).
The rise was larger in people who already had retinopathy at the start (8.2 per cent against 5.2 per cent) than in people who did not (0.7 per cent against 0.4 per cent). The label adds that rapid improvement in blood glucose control has been associated with a temporary worsening of diabetic retinopathy, that the effect of long-term control with semaglutide has not been studied, and that people with a history of retinopathy should be monitored.
The AAO puts it in proportion. For most people this will not be a problem and any symptoms are manageable, and it advises telling the ophthalmologist about every medicine being used and having regular eye checks so that vision changes are tracked. It also notes that a study called FOCUS is looking at the long-term effect on retinopathy and is expected to finish in February 2027.
Why is vision blurry since starting semaglutide?
Often because blood sugar is changing, and that is usually temporary. The AAO explains that a change in sugar level can alter the shape of the lens inside the eye, and that blurred vision is a known side effect when the medicine starts. Older people are more likely to notice it, because the lens is less flexible with age, so vision takes longer to settle. The retina specialist it quotes says this usually eases after three or four months.
The AAO's ophthalmologist answer on weight loss makes a related point: a large change in weight can change vision, especially when average blood sugar has changed a lot. That is a reason to tell the eye doctor about the medicine before a new glasses prescription is made, and to ask whether to wait a little first.
Gradual blur in both eyes is a different story from a sudden patch. A dark or missing area in one eye that appeared over minutes or hours, or new floating spots and cobwebs are not part of settling in. Tell a doctor the same day. Our page on sudden floaters and flashes explains the floating-spot signs.
Should someone on semaglutide still have the diabetic eye check?
Yes. A person with diabetes needs the dilated eye exam whatever medicine they take, and starting semaglutide is a good moment to confirm the date of the last one. The US National Eye Institute advises a comprehensive dilated eye exam at least once a year with diabetes, because the early stages of retinopathy usually cause no symptoms and finding it early helps protect vision.
The NHS describes the screening visit as about 30 minutes: a letter chart, drops to widen the pupils, and photographs of the back of the eye. The drops blur sight for a few hours, so arrange a lift home. The NHS invites people with diabetes aged 12 and over every one or two years. In Malaysia the schedule comes from your own doctor or clinic, so ask which interval applies and when the last one was.
If the person has no diabetes and uses semaglutide for weight, the diabetic check does not apply, but the sudden-loss warning above does. Our pages on diabetes in the family and eye checks for the whole family cover who needs which check.
What should I tell my doctor and the eye doctor?
Tell both of them the same few things, because each sees a different half of the picture. Bring the pen or box so the exact medicine is named. A short list is enough.
- The medicine and the month it started.
- Whether there is diabetes, and the date of the last dilated eye exam, including any retinopathy found before.
- Any earlier optic nerve problem or sudden loss of vision in either eye.
- Other conditions: high blood pressure, high cholesterol, sleep apnoea or heart disease.
- Any change since starting: blurring, a dark patch, floaters, or a brief darkening that came and went.
Then leave the decisions to the two doctors. The eye doctor examines and explains whether a change fits the medicine. The prescriber weighs the eye finding against what the medicine is doing for blood sugar, weight or the heart, and decides whether to continue. The AAO notes that these medicines offer real benefits for people with diabetes, obesity and heart disease, which is exactly why that decision is not made at the kitchen table.
Dr Chan sees adults as well as children, and this page explains who is seen. Another page, on a parent's long-term tablet and the eyes, covers other medicines that come with an eye check.
- Loses vision suddenly in one eye, usually without pain. Go the same day and name the medicine.
- Sees a dark or missing patch in one eye that does not clear, or vision that darkens for seconds or minutes and returns. Go the same day.
- Has new floating spots, streaks or cobwebs in the vision, especially with diabetes. Tell a doctor the same day.
- Is told to stop or change the medicine because of an eye finding. That decision belongs to the doctors, so contact the prescriber the same day.
Common questions
Does semaglutide cause blindness?
How common is NAION with semaglutide?
Should I stop semaglutide if my vision is blurry?
Can semaglutide make diabetic retinopathy worse?
How often should I have a diabetic eye check on semaglutide?
Does the same warning apply to tirzepatide and other GLP-1 medicines?
What should I tell my eye doctor if I am on semaglutide?
- European Medicines Agency · PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines (6 June 2025) · www.ema.europa.eu (opens in a new tab)
- American Academy of Ophthalmology · Can Ozempic affect eye health? What ophthalmologists want you to know · www.aao.org (opens in a new tab)
- American Academy of Ophthalmology · What is ischemic optic neuropathy? · www.aao.org (opens in a new tab)
- US FDA prescribing information via DailyMed · Ozempic (semaglutide) injection, section 5.3 diabetic retinopathy complications · dailymed.nlm.nih.gov (opens in a new tab)
- NHS · Semaglutide · www.nhs.uk (opens in a new tab)
- National Eye Institute · Diabetic retinopathy · www.nei.nih.gov (opens in a new tab)
- NHS · Diabetic eye screening · www.nhs.uk (opens in a new tab)
- American Academy of Ophthalmology · Does large weight loss cause vision change? · www.aao.org (opens in a new tab)
